1 Min Read
May 9 (Reuters) - Repros Therapeutics Inc
* Repros Therapeutics Inc. reports first quarter 2017 financial results
* Q1 loss per share $0.22 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.